General Information of Drug Formulation (ID: F24392)

Formulation Name
Lonafarnib 50 mg capsule
Company
Eiger Biopharmaceuticals
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Lonafarnib DMGM2Z6 Hutchinson-Gilford progeria syndrome LD2B Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Ammonia E00007 222 Alkalizing agent
Butyl alcohol E00011 263 Flavoring agent; Solvent
Carmellose sodium E00625 Not Available Disintegrant
Colcothar yellow E00436 518696 Colorant
Ethanol E00023 702 Antimicrobial preservative; Penetration agent; Solvent
Ferric oxide black E00522 16211978 Colorant
Gelatin E00630 Not Available Other agent
Haematite red E00236 14833 Colorant
Isopropyl alcohol E00070 3776 Antimicrobial preservative; Solvent
Magnesium stearate E00208 11177 lubricant
Poloxamer 188 E00645 Not Available Emulsifying agent; Solubilizing agent; Surfactant
Potassium hydroxide E00233 14797 Alkalizing agent
Povidone E00667 Not Available Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Propylene glycol E00040 1030 Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Shellac E00695 Not Available Coating agent; Film/membrane-forming agent; Microencapsulating agent; Modified-release agent
Silicon dioxide E00670 Not Available Anticaking agent; Opacifying agent; Viscosity-controlling agent
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Water E00035 962 Solvent